Rita Scarpelli

3.1k total citations
48 papers, 2.0k citations indexed

About

Rita Scarpelli is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Rita Scarpelli has authored 48 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 21 papers in Pharmacology and 14 papers in Organic Chemistry. Recurrent topics in Rita Scarpelli's work include Cannabis and Cannabinoid Research (16 papers), Histone Deacetylase Inhibitors Research (6 papers) and Protein Degradation and Inhibitors (6 papers). Rita Scarpelli is often cited by papers focused on Cannabis and Cannabinoid Research (16 papers), Histone Deacetylase Inhibitors Research (6 papers) and Protein Degradation and Inhibitors (6 papers). Rita Scarpelli collaborates with scholars based in Italy, United States and Switzerland. Rita Scarpelli's co-authors include Philip Jones, Daniele Piomelli, Federica Ferrigno, Christian Steinkühler, Michael Rowley, Andrea Armirotti, Sergio Altamura, Tiziano Bandiera, Paola Lo Surdo and Jesus M. Ontoria and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Rita Scarpelli

46 papers receiving 1.9k citations

Peers

Countries citing papers authored by Rita Scarpelli

Since Specialization

Citations

This map shows the geographic impact of Rita Scarpelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita Scarpelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita Scarpelli more than expected).

Fields of papers citing papers by Rita Scarpelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita Scarpelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita Scarpelli. The network helps show where Rita Scarpelli may publish in the future.

Co-authorship network of co-authors of Rita Scarpelli

This figure shows the co-authorship network connecting the top 25 collaborators of Rita Scarpelli. A scholar is included among the top collaborators of Rita Scarpelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita Scarpelli. Rita Scarpelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	METTL9 sustains vertebrate neural development primarily via non-catalytic functions 2025 ·Nature Communications ·(unknown), (unknown), (unknown), (unknown), Helena Santos-Rosa, Martina Palomba, (unknown), Stefania Girotto, Rita Scarpelli, Shi‐Lu Luan, (unknown), Paolo Bianchini, Andrew J. Bannister, Stefano Gustincich, Tony Kouzarides, Roberto Rizzo, Isaia Barbieri, Federico Cremisi, Robert Vignali, Luca Pandolfini	0
2	Exploration of the Neuromodulatory Properties of Fyn and GSK-3β Kinases Exploiting 7-Azaindole-Based Inhibitors 2025 ·Journal of Medicinal Chemistry ·(unknown), Francesca Massenzio, José Antonio Ortega, Debora Russo, Ilaria Penna, Federico Falchi, (unknown), Sabrina Petralla, Rita Scarpelli, (unknown), Gert Fricker, Michela Rosini, Andrea Cavalli, Barbara Monti, Anna Minarini, (unknown)	1
3	Environmentally Sustainable Preparation of Oleuropein and Its Dialdehydic Derivatives in a Simple Pharmaceutical Formulation 2024 ·ChemSusChem ·Mónica Nardi, Sonia Bonacci, (unknown), Manuela Oliverio, Rita Scarpelli, Antonio Procopio	0
4	Identification of a Dual Autophagy and REV-ERB Inhibitor with in Vivo Anticancer Efficacy 2023 ·Journal of Medicinal Chemistry ·Martina Palomba, (unknown), Giulia Allavena, (unknown), Claudia De Mei, Rita Scarpelli, Benedetto Grimaldi	4
5	Potentiation of endocannabinoids and other lipid amides prevents hyperalgesia and inflammation in a pre-clinical model of migraine 2022 ·The Journal of Headache and Pain ·Rosaria Greco, Chiara Demartini, Anna Maria Zanaboni, (unknown), Angelo Reggiani, Natalia Realini, Rita Scarpelli, Daniele Piomelli, Cristina Tassorelli	10
6	Design, Synthesis, and Biological Evaluation of a Series of Oxazolone Carboxamides as a Novel Class of Acid Ceramidase Inhibitors 2020 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), Marco Mazzonna, Debora Russo, Ilaria Penna, Maria Summa, Sine Mandrup Bertozzi, Natalia Realini, (unknown), Marco Migliore, Giuliana Ottonello, Min Liu, Peter T. Lansbury, Andrea Armirotti, Rosalia Bertorelli, Soumya S. Ray, Renato T. Skerlj, Rita Scarpelli	13
7	Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies 2015 ·European Journal of Medicinal Chemistry ·Marco Migliore, Damien Habrant, Oscar Sasso, Clara Albani, Sine Mandrup Bertozzi, Andrea Armirotti, Daniele Piomelli, Rita Scarpelli	32
8	Fluorine nuclear magnetic resonance-based assay in living mammalian cells 2015 ·Analytical Biochemistry ·Marina Veronesi, (unknown), Elisa Romeo, (unknown), Giuliana Ottonello, Chiara Lambruschini, G. Garau, Rita Scarpelli, Tiziano Bandiera, Daniele Piomelli, Claudio Dalvit	30
9	Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti‐inflammatory drug‐dependent gastrointestinal damage 2015 ·The FASEB Journal ·Oscar Sasso, Marco Migliore, Damien Habrant, Andrea Armirotti, Clara Albani, Maria Summa, Guillermo Moreno‐Sanz, Rita Scarpelli, Daniele Piomelli	57
10	Structural determinants of peripheral O-arylcarbamate FAAH inhibitors render them dual substrates for Abcb1 and Abcg2 and restrict their access to the brain 2014 ·Pharmacological Research ·Guillermo Moreno‐Sanz, (unknown), Andrea Armirotti, Sine Mandrup Bertozzi, Rita Scarpelli, Tiziano Bandiera, Julio G. Prieto, Andrea Duranti, Giorgio Tarzia, Gracia Merino, Daniele Piomelli	8
11	Multitarget Drug Discovery for Alzheimer's Disease: Triazinones as BACE‐1 and GSK‐3β Inhibitors 2014 ·Angewandte Chemie International Edition ·Federica Prati, Angela De Simone, Paola Bisignano, Andrea Armirotti, Maria Summa, Daniela Pizzirani, Rita Scarpelli, Daniel I. Pérez, Vincenza Andrisano, Ana Pérez‐Castillo, Barbara Monti, Francesca Massenzio, Letizia Polito, Marco Racchi, Angelo D. Favia, Giovanni Bottegoni, Ana Martı́nez, María Laura Bolognesi, Andrea Cavalli	102
12	Dual inhibition of REV-ERBβ and autophagy as a novel pharmacological approach to induce cytotoxicity in cancer cells 2014 ·Oncogene ·Claudia De Mei, (unknown), Chiara Parodi, Marina Veronesi, (unknown), Giovanni Bottegoni, Esther Torrente, Rita Scarpelli, Roberto Marotta, (unknown), Michela Mattioli, Angelo Reggiani, Mark Wade, Benedetto Grimaldi	94
13	Development of Fragment‐Based n‐FABS NMR Screening Applied to the Membrane Enzyme FAAH 2013 ·ChemBioChem ·Chiara Lambruschini, Marina Veronesi, Elisa Romeo, G. Garau, Tiziano Bandiera, Daniele Piomelli, Rita Scarpelli, Claudio Dalvit	19
14	Fluorine NMR‐Based Screening on Cell Membrane Extracts 2013 ·ChemMedChem ·Marina Veronesi, Elisa Romeo, Chiara Lambruschini, Daniele Piomelli, Tiziano Bandiera, Rita Scarpelli, G. Garau, Claudio Dalvit	10
15	Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions 2012 ·Pharmacological Research ·Oscar Sasso, Rosalia Bertorelli, Tiziano Bandiera, Rita Scarpelli, Giampiero Colombano, Andrea Armirotti, Guillermo Moreno‐Sanz, Angelo Reggiani, Daniele Piomelli	76
16	Studies of the metabolic stability in cells of 5-(trifluoroacetyl)thiophene-2-carboxamides and identification of more stable class II histone deacetylase (HDAC) inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Rita Scarpelli, Annalise Di Marco, Federica Ferrigno, Ralph Laufer, (unknown), Ester Muraglia, Jesus M. Ontoria, Michael Rowley, Sergio Serafini, Christian Steinkühler, Philip Jones	17
17	Structural and Functional Analysis of the Human HDAC4 Catalytic Domain Reveals a Regulatory Structural Zinc-binding Domain 2008 ·Journal of Biological Chemistry ·Matthew J. Bottomley, Paola Lo Surdo, Paolo Di Giovine, Agostino Cirillo, Rita Scarpelli, Federica Ferrigno, Philip Jones, Petra Neddermann, Raffaele De Francesco, Christian Steinkühler, Paola Gallinari, Andrea Carfı́	261
18	A series of novel, potent, and selective histone deacetylase inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Philip Jones, Sergio Altamura, Prasun K. Chakravarty, (unknown), Raffaele De Francesco, Paola Gallinari, Raffaele Ingenito, Peter T. Meinke, Alessia Petrocchi, Michael Rowley, Rita Scarpelli, Sergio Serafini, Christian Steinkühler	52
19	Chemical synthesis and biological properties of pyridine epothilones 2000 ·Chemistry & Biology ·K. C. Nicolaou, Rita Scarpelli, Birgit Bollbuck, (unknown), M. Manuela A. Pereira, Markus Wartmann, (unknown), Daniel Zaharevitz, Rick Gussio, P. Giannakakou	125
20	Total Synthesis of 16-Desmethylepothilone B, Epothilone B10, Epothilone F, and Related Side Chain Modified Epothilone B Analogues 2000 ·Chemistry - A European Journal ·K. C. Nicolaou, David Hepworth, N. Paul King, M. Raymond V. Finlay, Rita Scarpelli, M. Manuela A. Pereira, Birgit Bollbuck, Antony Bigot, (unknown), Nicolas Winssinger	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact